DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 234 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q4 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $506,464 | -16.0% | 47,600 | -17.6% | 0.00% | -20.0% |
Q3 2022 | $603,000 | +59.9% | 57,750 | +65.9% | 0.01% | +66.7% |
Q1 2022 | $377,000 | +55.1% | 34,800 | +101.2% | 0.00% | +50.0% |
Q4 2021 | $243,000 | -33.8% | 17,300 | -79.6% | 0.00% | -71.4% |
Q3 2020 | $367,000 | -49.9% | 84,834 | +76.4% | 0.01% | -82.5% |
Q2 2018 | $733,000 | +40.4% | 48,100 | +82.8% | 0.04% | +2.6% |
Q1 2018 | $522,000 | +13.0% | 26,308 | +6.5% | 0.04% | +2.6% |
Q4 2017 | $462,000 | +158.1% | 24,699 | +44.7% | 0.04% | +26.7% |
Q3 2016 | $179,000 | – | 17,070 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chicago Capital, LLC | 5,791,735 | $85,543,929 | 4.00% |
Deep Track Capital, LP | 6,756,956 | $99,800,240 | 3.85% |
Intrinsic Edge Capital Management LLC | 1,133,099 | $16,735,872 | 1.89% |
Bain Capital Life Sciences Investors, LLC | 915,000 | $13,514,550 | 1.51% |
Kynam Capital Management, LP | 500,000 | $7,385,000 | 1.21% |
Rhenman & Partners Asset Management AB | 700,000 | $10,339,000 | 1.12% |
AlphaCentric Advisors LLC | 110,000 | $1,624,700 | 0.92% |
HighVista Strategies LLC | 133,000 | $1,964,410 | 0.91% |
Affinity Asset Advisors, LLC | 200,000 | $2,954,000 | 0.83% |
Rock Springs Capital Management LP | 1,813,758 | $26,789,206 | 0.72% |